Literature DB >> 18711461

Multicenter study of compliance and drop administration in glaucoma.

Ramin Kholdebarin1, Robert J Campbell, Ya-Ping Jin, Yvonne M Buys.   

Abstract

BACKGROUND: Poor compliance with medication is a major concern in the management of glaucoma. Improper administration technique can lead to contamination and inaccurate dosing. This study estimates the prevalence and predictors of noncompliance and improper administration technique among Canadian glaucoma patients.
METHODS: Data were collected using a standardized questionnaire. Noncompliance was defined as missing at least 1 drop of medication per week and (or) the inability to accurately describe the medication regimen. Patients were asked to indicate the most common reason for missing medication. Study personnel assessed drop administration technique as patients were applying eye drops. Physicians provided information, including measures of disease stability, regarding the patient's glaucoma. Predictors were assessed using odds ratios from a logistic regression model.
RESULTS: 500 patients from 10 centers across Canada participated in the study. Of these, 25.6% reported missing at least 1 drop of medication per week, and 4.2% were unable to accurately describe their medication regimen. The overall proportion of noncompliance was 27.9%. With regard to drop administration, 6.8% missed their eye and 28.8% contaminated the bottle tip; overall, 33.8% demonstrated improper technique. The most common reasons given for missing eye drops were "forgetfulness" and "being away from drops." Formal education limited to elementary school and treatment duration of <5 years increased patient-reported noncompliance. Factors associated with improper administration technique were age 60 years and older and formal education limited to elementary school.
INTERPRETATION: Over 50% of the patients surveyed were either noncompliant or demonstrated improper administration technique. Glaucoma patients should be educated on the importance of compliance and instructed on proper drop administration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18711461     DOI: 10.1139/i08-076

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  54 in total

1.  A novel eye drop application monitor to assess patient compliance with a prescribed regimen: a pilot study.

Authors:  A M Eaton; G M Gordon; A Konowal; A Allen; M Allen; A Sgarlata; G Gao; H Wafapoor; R L Avery
Journal:  Eye (Lond)       Date:  2015-09-11       Impact factor: 3.775

2.  Glaucoma.

Authors:  Chris J Hong; Graham E Trope
Journal:  CMAJ       Date:  2014-11-24       Impact factor: 8.262

3.  [Preservative-containing eye drops and adherence in ophthalmological practice].

Authors:  I Lanzl; T Kaercher
Journal:  Ophthalmologe       Date:  2012-11       Impact factor: 1.059

4.  Compliance and knowledge about glaucoma in patients at tertiary glaucoma units.

Authors:  Kaweh Mansouri; Milko E Iliev; Kaspar Rohrer; Tarek Shaarawy
Journal:  Int Ophthalmol       Date:  2011-10-07       Impact factor: 2.031

5.  First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results.

Authors:  Jordana K Schmier; David W Covert
Journal:  Clin Ophthalmol       Date:  2010-05-14

6.  Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy.

Authors:  Gregory Reardon; Gail F Schwartz; Sameer Kotak
Journal:  BMC Ophthalmol       Date:  2010-03-02       Impact factor: 2.209

7.  First-year treatment costs among new initiators of topical prostaglandin analogs.

Authors:  Jordana K Schmier; David W Covert; Alan L Robin
Journal:  Clin Ophthalmol       Date:  2009-11-16

8.  Extended release of timolol from nanoparticle-loaded fornix insert for glaucoma therapy.

Authors:  Hyun Jung Jung; Anuj Chauhan
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-03       Impact factor: 2.671

9.  The association between compliance with recommended follow-up and glaucomatous disease severity in a county hospital population.

Authors:  Cindy Ung; Yohko Murakami; Elisa Zhang; Tatyana Alfaro; Monica Zhang; Michael I Seider; Kuldev Singh; Shan C Lin
Journal:  Am J Ophthalmol       Date:  2013-04-17       Impact factor: 5.258

10.  Medical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistency.

Authors:  Sadhana V Kulkarni; Karim F Damji; Yvonne M Buys
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.